| QUVIVIQ 25 mg film-coated tablets EU/1/22/1638/001-002 |
Daridorexant hydrochloride |
Idorsia Pharmaceuticals Deutschland GmbH |
— |
| QUVIVIQ 50 mg film-coated tablets EU/1/22/1638/003-004 |
Daridorexant hydrochloride |
Idorsia Pharmaceuticals Deutschland GmbH |
— |
| Raloxifene Teva 60 mg film-coated tablets EU/1/10/627/1-3 |
Raloxifene hydrochloride |
Teva B.V. |
— |
| Ranexa 375 mg prolonged-release tablets EU/1/08/462/1,2,7,8 |
Ranolazine |
Menarini International Operations Luxembourg S.A. |
— |
| Ranexa 500 mg prolonged-release tablets EU/1/08/462/3,4,9,10 |
Ranolazine |
Menarini International Operations Luxembourg S.A. |
— |
| Ranexa 750 mg prolonged-release tablets EU/1/08/462/5,6,11,12 |
Ranolazine |
Menarini International Operations Luxembourg S.A. |
— |
| Ranivisio 10 mg/ml solution for injection EU/1/22/1673/001 |
Ranibizumab |
Midas Pharma GmbH |
— |
| Rapamune EU/1/01/171/14 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 0.5 mg Coated tablet EU/1/01/171/013-014 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/007 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg Coated tablet EU/1/01/171/008 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 1 mg/ml Oral solution EU/1/01/171/001 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapamune 2 mg Coated tablet EU/1/01/171/009-010 |
Sirolimus |
Pfizer Europe MA EEIG |
— |
| Rapilysin 10 U powder and solvent for solution for injection. EU/1/96/018/001 |
Reteplase |
Actavis Group hf |
— |
| Rapiscan 400 microgram solution for injection EU/1/10/643/001 |
Regadenoson |
GE Healthcare AS |
— |
| Rasagiline Mylan 1 mg tablets EU/1/16/1090/001-012 |
Rasagiline |
Viatris Limited |
— |
| Rasagiline Ratiopharm 1 mg tablets EU/1/14/977/001-007 |
Rasagiline |
Teva B.V. |
— |
| Rasilez 150 mg film-coated tablets EU/1/07/405/021-030 |
Aliskiren hemifumarate |
Lxo Ireland Designated Activity Company |
— |
| Rasilez 300 mg film-coated tablets EU/1/07/405/031-040 |
Aliskiren hemifumarate |
Noden Pharma DAC |
— |
| Ratiograstim 30 MIU/0.5 ml solution for injection EU/1/08/444/1-4 |
Filgrastim |
Ratiopharm GmbH |
— |
| Ratiograstim 48 MIU/0.8 ml solution for injection EU/1/08/444/5-8 |
Filgrastim |
Ratiopharm GmbH |
— |
| RAVICTI 1.1 g/ml oral liquid EU/1/15/1062/001-004 |
Glycerol phenylbutyrate |
Immedica Pharma AB |
— |
| Raxone 150 mg film-coated tablets EU/1/15/1020/001 |
Idebenone |
Chiesi Farmaceutici S.p.A. |
— |
| RAYVOW 100 mg film-coated tablets EU/1/21/1587/011-020 |
Lasmiditan Succinate |
Eli Lilly Nederland B.V. |
— |
| RAYVOW 200 mg film-coated tablets EU/1/21/1587/021-030 |
Lasmiditan Succinate |
Eli Lilly Nederland B.V. |
— |
| RAYVOW 50 mg film-coated tablets EU/1/21/1587/001-010 |
Lasmiditan Succinate |
Eli Lilly Nederland B.V. |
— |
| Razole 10 mg Gastro-resistant tablets PA0074/073/001 |
Rabeprazole sodium |
Rowa Pharmaceuticals Limited |
Not marketed |
| Razole 20 mg Gastro-resistant tablets PA0074/073/002 |
Rabeprazole sodium |
Rowa Pharmaceuticals Limited |
Not marketed |
| Reagila 1.5 mg hard capsules EU/1/17/1209/001-010 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 1.5 mg orodispersible tablets EU/1/17/1209/043-044 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 3 mg hard capsules EU/1/17/1209/011-020 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 3 mg orodispersible tablets EU/1/17/1209/045-046 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 4.5 mg hard capsules EU/1/17/1209/021-028 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 4.5 mg orodispersible tablets EU/1/17/1209/047-048 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 6 mg hard capsules EU/1/17/1209/029-036 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Reagila 6 mg orodispersible tablets EU/1/17/1209/049-050 |
Cariprazine hydrochloride |
Gedeon Richter Plc |
— |
| Rebif 22 micrograms solution for injection in pre-filled syringe EU/1/98/063/001,11-13 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 22 micrograms solution for injection in pre-filled syringe EU/1/98/063/002 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 22 micrograms solution for injection in pre-filled syringe EU/1/98/063/003 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 22 micrograms/0.5 mL solution for injection in cartridge EU/1/98/063/008,18 |
Interferon beta-1-a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms solution for injection in pre-filled syringe EU/1/98/063/004 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms solution for injection in pre-filled syringe EU/1/98/063/005 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms solution for injection in pre-filled syringe EU/1/98/063/006 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 44 micrograms/0.5 mL solution for injection in cartridge EU/1/98/063/009,019 |
Interferon beta-1-a |
Merck Europe B.V. |
— |
| Rebif 8.8 micrograms + 22 micrograms solution for injection in pre-filled pen Initiation pack EU/1/98/063/017 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 8.8 micrograms + 22 micrograms solution for injection in pre-filled syringe Starter Pack EU/1/98/063/007 |
Interferon beta - 1a |
Merck Europe B.V. |
— |
| Rebif 8.8 micrograms/0.1 mL + 22 micrograms/0.25 mL solution for injection in cartridge Initiation pack EU/1/98/063/010 |
Interferon beta-1-a |
Merck Europe B.V. |
— |
| Reblozyl 25 mg powder for solution for injection EU/1/20/1452/001 |
Luspatercept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Reblozyl 75 mg powder for solution for injection EU/1/20/1452/002 |
Luspatercept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Recarbrio 500 mg/500 mg/250 mg powder for solution for infusion EU/1/19/1420/001 |
Imipenem, Cilastatin, Relebactam |
Merck Sharp & Dohme BV, |
— |